论文部分内容阅读
目的:探讨复方米非司酮用于疤痕子宫流产的效果。方法:剖宫产术后再次妊娠孕≤10周妇女310例自愿要求药物流产作为观察组,同期非疤痕子宫施行药物流产妇女310例作为对照组。两组均给于复方米非司酮配合米索前列醇口服流产,若在0.5h内呕吐或3h未排出孕囊再补米索前列醇。结果:两组对象年龄、孕产次、停经天数、孕囊大小差异无统计学意义(P>0.05);两组流产效果比较差异无统计学意义(P>0.05);两组出血量比较差异无统计学意义(P>0.05);两组阴道出血时间观察组为(13.2土8.7)天,对照组为(13.1±8.5)天,两组差异无统计学意义(P>0.05)。结论:复方米非司酮对瘢痕子宫妊娠流产与非瘢痕子宫妊娠流产同样具有很好的临床疗效。
Objective: To investigate the effect of compound mifepristone on abortion of scar. Methods: 310 women with pregnancy less than 10 weeks after cesarean delivery were asked for medical abortion voluntarily as the observation group, and 310 women with medical abortion during the same period as the control group. Both groups were given compound mifepristone with misoprostol oral abortion, if vomiting within 0.5h or 3h pregnant women were not discharged pregnant rice replenishment of misoprostol. Results: There was no significant difference in age, pregnancy time, days of menopause, gestational sac size between the two groups (P> 0.05). There was no significant difference in abortion outcome between the two groups (P> 0.05) There was no significant difference between the two groups (P> 0.05). The vaginal bleeding time in the two groups was (13.2 ± 8.7 days) in observation group and (13.1 ± 8.5) days in control group. There was no significant difference between the two groups (P> 0.05). CONCLUSION: Compound mifepristone has the same good curative effect on abortion of non-scarring uterine pregnancy and uterine scar pregnancy.